🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study Title A post market registry of Abluminus® sirolimus eluting coronary...
Status
Unknown
Location
IRCCS Pol. San Donato
Start Date
2017-01
Trial ID
NCT03509532
Treatments Being Tested
The primary objective of the study is to assess the safety and the efficacy...
Status
Recruiting
Location
Geneva University Hospitals
Start Date
2026-04-01
Trial ID
NCT06710210
Treatments Being Tested
This study sought to compare procedural performance of a new coronary stent...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02881216
Treatments Being Tested
Hypothesis: Sealing moderate SVG lesions with paclitaxel-eluting stents red...
Status
Terminated
Location
Institut universitaire de cardiologie et de pneumologie de Québec
Start Date
2010-04
Trial ID
NCT01223443
Treatments Being Tested
It is a multi-center randomized clinical trial (RCT) which will enroll 3746...
Status
Unknown
Location
First Affiliated Hospital of Nanjing Medical University
Start Date
2018-02-03
Trial ID
NCT03234114
Treatments Being Tested
The aim of the Danish Organization for Randomized Trials with Clinical Outc...
Status
Unknown
Location
Odense University Hospital
Start Date
2015-12
Trial ID
NCT02623140
Treatments Being Tested
Patients with stable coronary artery disease, undergoing PCI by means of im...
Status
Terminated
Location
University of Turin
Start Date
2007-10
Trial ID
NCT01454440
Treatments Being Tested
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy (STICH3C)...
Status
Recruiting
Location
Cedars-Sinai
Start Date
2023-06-22
Trial ID
NCT05427370
Treatments Being Tested
The XIENCE 28 USA Study is prospective, single arm, multi-center, open labe...
Status
Completed
Location
Heart Center Research, LLC
Start Date
2019-02-25
Trial ID
NCT03815175
Treatments Being Tested